查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1720556

格林-巴利症候群(GBS)诊断的全球市场 - 市场规模，占有率，趋势，产业分析:检查别，各最终用途，各地区 - 市场预测(2025年～2034年)

Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2034 年，全球格林-巴利症候群 (GBS) 诊断市场规模将达到 1.9071 亿美元。

格林-巴利症候群 (GBS) 的诊断需要结合临床评估和神经传导研究、腰椎穿刺等检查，以确认是否存在这种影响週边神经系统的罕见自体免疫疾病。

医疗诊断技术的进步正在推动 GBS 诊断市场的成长。更新、更先进的工具，例如高解析度神经传导研究和改进的腰椎穿刺技术，使医疗保健专业人员能够比以往更准确、更快速地诊断 GBS。这些进展正在降低误诊率，并减少可能导致患者病情恶化的治疗延误。此外，创新的诊断平台为患者和医疗保健专业人员提供了非侵入性、更快速、更经济的治疗方案，有助于有效识别和治疗格林巴利症候群 (GBS)。这些持续的技术创新正在推动格林巴利症候群 (GBS) 诊断市场的扩张。

医学研究资金的增加对格林-巴利症候群 (GBS) 诊断市场的趋势产生了重大影响。政府、私人组织和医疗保健机构正在投入更多资源，用于研究格林-巴利综合症 (GBS)、其病因以及提高诊断效率。这些投资正在推动新方法、工具和技术的开发，从而提高诊断准确性并缩短诊断时间。研究经费也加深了我们对格林-巴利症候群的理解，进而带来更有效的检测策略。格林巴利症候群研究的资助持续推动先进诊断解决方案的普及，使患者更容易获得早期发现和治疗。

格林-巴利症候群 (GBS) 诊断市场报告重点

从最终用途来看，由于医院和诊所拥有诊断格林巴利症候群 (GBS) 所需的资源，因此在 2024 年，医院和诊所占据了格林巴利症候群 (GBS) 诊断市场的主导占有率。

从检测角度来看，腰椎穿刺细分市场预计将在预测期内成长最快，因为它是一项关键检测，透过分析脑脊髓液中升高的蛋白质浓度来帮助诊断格林-巴利症候群。

由于北美拥有先进的医疗基础设施和对罕见疾病的高度认知，北美在 2024 年占据了 GBS 诊断市场的收入占有率。

由于医疗基础设施的改善和对罕见疾病认知度的提高，预计亚太地区将在预测期内占据显着占有率。

全球市场的主要参与者包括Alpine Biomed，Bionen Medical Devices，Cadwell Industries, Inc，Deymed Diagnostic，EMS Biomedical，Medtronic plc，Natus Medical Incorporated，Neurosoft，Nihon Kohden Corporation，Rochester Electro-Medical, Inc.等。

本报告提供全球格林-巴利症候群(GBS)诊断市场相关调查，提供目前市场动态的详细的考察，及未来市场成长相关分析。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球格林-巴利症候群(GBS)诊断市场考察

  • 市场概述
  • 格林-巴利症候群 (GBS) 诊断的市场动态
    • 推动因素与机遇
      • 老年人口不断增加
      • 格林-巴利症候群 (GBS) 盛行率不断上升
    • 限制与课题
      • 熟练劳动力短缺
  • PESTEL分析
  • 格林-巴利症候群(GBS)诊断市场最终用途趋势
  • 价值链分析
  • COVID-19影响的分析

第5章 全球格林-巴利症候群(GBS)诊断市场:检查别

  • 主要调查结果
  • 简介
  • 腰椎穿刺
  • 神经传导
  • 肌电图检验
  • 其他

第6章 全球格林-巴利症候群(GBS)诊断市场:各最终用途

  • 主要调查结果
  • 简介
  • 医院·诊疗所
  • 诊断研究所
  • 其他

第7章 全球格林-巴利症候群(GBS)诊断市场:各地区

  • 主要调查结果
  • 简介
    • 格林-巴利症候群(GBS)诊断市场分析:各地区(2020年～2034年)
  • 北美
    • 北美:试验(2020年～2034年)
    • 北美:各最终用途(2020年～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:试验(2020年～2034年)
    • 欧洲:各最终用途(2020年～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他的欧洲
  • 亚太地区
    • 亚太地区:试验(2020年～2034年)
    • 亚太地区:各最终用途(2020年～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东·非洲
    • 中东·非洲:试验(2020年～2034年)
    • 中东·非洲:各最终用途(2020年～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他的中东·非洲
  • 南美
    • 南美:试验(2020年～2034年)
    • 南美:各最终用途(2020年～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 伙伴关係/合作/协定/公开

第9章 企业简介

  • Alpine Biomed
  • Bionen Medical Devices
  • Cadwell Industries, Inc
  • Deymed Diagnostic
  • EMS Biomedical
  • Medtronic plc
  • Natus Medical Incorporated
  • Neurosoft
  • Nihon Kohden Corporation
  • Rochester Electro-Medical, Inc.
Product Code: PM5538

The Guillain-Barre syndrome (GBS) diagnostics market size is expected to reach USD 190.71 million by 2034, according to a new study by Polaris Market Research. The report "Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test (Lumber Puncture, Nerve Conduction, Electromyography, and Others), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Guillain-Barre Syndrome (GBS) diagnostics involves a combination of clinical evaluation and tests such as nerve conduction studies and lumbar puncture to confirm the presence of this rare autoimmune disorder affecting the peripheral nervous system.

Technological advancements in medical diagnostics are driving the GBS diagnostics market growth. Newer, more sophisticated tools such as high-resolution nerve conduction studies and improved lumbar punctures allow healthcare professionals to diagnose GBS more accurately and faster than before. These developments have reduced the chances of misdiagnosis, which delay treatment and worsen the patient's condition. Moreover, innovative diagnostic platforms now offer noninvasive, quicker, and more affordable options for both patients and healthcare providers, making it easier to identify and treat GBS effectively. These ongoing innovations are driving the Guillain-Barre syndrome diagnostics market expansion.

Increasing funding for medical research has significantly impacted the Guillain-Barre Syndrome diagnostics market trends. Governments, private organizations, and healthcare institutions are investing more resources into studying GBS, its causes, and improving diagnostic efficiency. These investments have led to the development of new methods, tools, and technologies that improve accuracy and reduce diagnosis time. Research funding has also deepened the understanding of the disease, leading to more effective detection strategies. Financial support for GBS research continues to drive the availability of advanced diagnostic solutions, making early detection and treatment more accessible to patients.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

A few global key market players are Alpine Biomed; Bionen Medical Devices; Cadwell Industries, Inc; Deymed Diagnostic; EMS Biomedical; Medtronic plc; Natus Medical Incorporated; Neurosoft; Nihon Kohden Corporation; and Rochester Electro-Medical, Inc.

Polaris Market Research has segmented the Guillain-Barre syndrome diagnostics market report on the basis of test, end use, and region:

By Test (Revenue - USD Million, 2020-2034)

  • Lumbar Puncture
  • Nerve Conduction
  • Electromyography
  • Other

By End Use (Revenue - USD Million, 2020-2034)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Guillain-Barre Syndrome Diagnostics Market Insights

  • 4.1. Guillain-Barre Syndrome Diagnostics Market - Market Snapshot
  • 4.2. Guillain-Barre Syndrome Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Prevalence of Guillain-Barre Syndrome
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Guillain-Barre Syndrome Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Guillain-Barre Syndrome Diagnostics Market, by Test

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 5.3. Lumbar Puncture
    • 5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
  • 5.4. Nerve Conduction
    • 5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
  • 5.5. Electromyography
    • 5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
  • 5.6. Other
    • 5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

6. Global Guillain-Barre Syndrome Diagnostics Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Guillain-Barre Syndrome Diagnostics Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Guillain-Barre Syndrome Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Guillain-Barre Syndrome Diagnostics Market - North America
    • 7.3.1. North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.3.2. North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.3. Guillain-Barre Syndrome Diagnostics Market - U.S.
      • 7.3.3.1. U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.4. Guillain-Barre Syndrome Diagnostics Market - Canada
      • 7.3.4.1. Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.4. Guillain-Barre Syndrome Diagnostics Market - Europe
    • 7.4.1. Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.4.2. Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.3. Guillain-Barre Syndrome Diagnostics Market - UK
      • 7.4.3.1. UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.4. Guillain-Barre Syndrome Diagnostics Market - France
      • 7.4.4.1. France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.4.2. France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.5. Guillain-Barre Syndrome Diagnostics Market - Germany
      • 7.4.5.1. Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.6. Guillain-Barre Syndrome Diagnostics Market - Italy
      • 7.4.6.1. Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.7. Guillain-Barre Syndrome Diagnostics Market - Spain
      • 7.4.7.1. Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.8. Guillain-Barre Syndrome Diagnostics Market - Netherlands
      • 7.4.8.1. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.9. Guillain-Barre Syndrome Diagnostics Market - Russia
      • 7.4.9.1. Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.5. Guillain-Barre Syndrome Diagnostics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.3. Guillain-Barre Syndrome Diagnostics Market - China
      • 7.5.3.1. China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.3.2. China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.4. Guillain-Barre Syndrome Diagnostics Market - India
      • 7.5.4.1. India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.4.2. India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.5. Guillain-Barre Syndrome Diagnostics Market - Malaysia
      • 7.5.5.1. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.6. Guillain-Barre Syndrome Diagnostics Market - Japan
      • 7.5.6.1. Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.7. Guillain-Barre Syndrome Diagnostics Market - Indonesia
      • 7.5.7.1. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.8. Guillain-Barre Syndrome Diagnostics Market - South Korea
      • 7.5.8.1. South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.9. Guillain-Barre Syndrome Diagnostics Market - Australia
      • 7.5.9.1. Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.6. Guillain-Barre Syndrome Diagnostics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.3. Guillain-Barre Syndrome Diagnostics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.4. Guillain-Barre Syndrome Diagnostics Market - UAE
      • 7.6.4.1. UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.5. Guillain-Barre Syndrome Diagnostics Market - Israel
      • 7.6.5.1. Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.6. Guillain-Barre Syndrome Diagnostics Market - South Africa
      • 7.6.6.1. South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.7. Guillain-Barre Syndrome Diagnostics Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.7. Guillain-Barre Syndrome Diagnostics Market - Latin America
    • 7.7.1. Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.3. Guillain-Barre Syndrome Diagnostics Market - Mexico
      • 7.7.3.1. Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.4. Guillain-Barre Syndrome Diagnostics Market - Brazil
      • 7.7.4.1. Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.5. Guillain-Barre Syndrome Diagnostics Market - Argentina
      • 7.7.5.1. Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.6. Guillain-Barre Syndrome Diagnostics Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alpine Biomed
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bionen Medical Devices
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cadwell Industries, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Deymed Diagnostic
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. EMS Biomedical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Medtronic plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Natus Medical Incorporated
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Neurosoft
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Nihon Kohden Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Rochester Electro-Medical, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 2 Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 3 North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 4 North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 5 U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 6 U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 7 Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 8 Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 9 Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 10 Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 11 UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 12 UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 13 France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 14 France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 15 Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 16 Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 18 Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 19 Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 20 Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 22 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 23 Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 24 Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 29 China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 30 China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 31 India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 32 India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 34 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 35 Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 36 Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 38 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 39 South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 40 South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 42 Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 49 UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 50 UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 52 Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 53 South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 54 South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 57 Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 58 Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 59 Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 60 Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 62 Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 63 Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 64 Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Guillain-Barre Syndrome Diagnostics Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Test
  • Figure 7. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2024 & 2034 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2024 & 2034 (USD Million)